Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-02-25 @ 7:22 PM
Study NCT ID:
NCT01662102
Status:
TERMINATED
Last Update Posted:
2021-10-04
First Post:
2012-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-03
First Submit QC Date:
None
Study First Post Date:
2012-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-16
Results First Submit QC Date:
None
Results First Post Date:
2016-01-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-06
Last Update Post Date:
2021-10-04
Last Update Post Date Type:
ACTUAL